Dr. John Baker, MD

NPI: 1548225519
Total Payments
$21,224
2024 Payments
$332.58
Companies
21
Transactions
340
Medicare Patients
1,225
Medicare Billing
$167,506

Payment Breakdown by Category

Other$14,900 (70.2%)
Food & Beverage$5,837 (27.5%)
Travel$420.92 (2.0%)
Education$66.03 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $14,900 16 70.2%
Food and Beverage $5,837 315 27.5%
Travel and Lodging $420.92 6 2.0%
Education $66.03 3 0.3%

Top Paying Companies

Company Total Records Latest Year
Indivior Inc. $15,794 35 $0 (2024)
Otsuka America Pharmaceutical, Inc. $1,223 65 $0 (2024)
Sunovion Pharmaceuticals Inc. $990.99 59 $0 (2020)
Janssen Pharmaceuticals, Inc $500.97 27 $0 (2023)
Allergan, Inc. $379.25 15 $0 (2020)
Lundbeck LLC $360.62 26 $0 (2024)
Vanda Pharmaceuticals Inc. $342.79 24 $0 (2020)
Alkermes, Inc. $341.98 20 $0 (2024)
Neurocrine Biosciences, Inc. $291.85 15 $0 (2024)
ITI, Inc. $175.29 10 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $332.58 17 Otsuka America Pharmaceutical, Inc. ($62.42)
2023 $351.63 18 Otsuka America Pharmaceutical, Inc. ($119.72)
2022 $204.32 12 ITI, Inc. ($155.02)
2021 $781.67 5 Indivior Inc. ($715.69)
2020 $2,877 33 Indivior Inc. ($2,417)
2019 $13,931 113 Indivior Inc. ($12,574)
2018 $1,845 95 Otsuka America Pharmaceutical, Inc. ($409.95)
2017 $900.81 47 Sunovion Pharmaceuticals Inc. ($317.91)

All Payment Transactions

340 individual payment records from CMS Open Payments — Page 1 of 14

Date Company Product Nature Form Amount Type
12/12/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $16.25 General
Category: CNS
11/13/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $13.28 General
Category: PSYCHIATRY
08/21/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $14.72 General
Category: PSYCHIATRY
07/31/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $25.32 General
Category: PSYCHIATRY
07/24/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $17.29 General
Category: NEUROSCIENCE
06/19/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $14.17 General
Category: PSYCHIATRY
06/12/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $22.87 General
Category: CNS
06/06/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.34 General
Category: NEUROSCIENCE
05/16/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $24.40 General
Category: NEUROSCIENCE
05/08/2024 Indivior Inc. PERSERIS (Drug) Food and Beverage In-kind items and services $24.10 General
Category: BH
04/10/2024 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug) Food and Beverage In-kind items and services $22.38 General
Category: PSYCHIATRY
04/04/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $14.17 General
Category: PSYCHIATRY
03/20/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $31.85 General
Category: Neuropsychiatry
03/13/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $16.99 General
Category: PSYCHIATRY
02/28/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $18.91 General
Category: CNS
02/21/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $16.43 General
Category: PSYCHIATRY
02/13/2024 Indivior Inc. PERSERIS (Drug) Food and Beverage In-kind items and services $25.11 General
Category: BH
12/07/2023 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug), REXULTI Food and Beverage In-kind items and services $17.97 General
Category: PSYCHIATRY
11/16/2023 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $15.36 General
Category: PSYCHIATRY
11/09/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $17.32 General
Category: NEUROSCIENCE
10/25/2023 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $15.65 General
Category: Neuroscience
10/19/2023 Otsuka America Pharmaceutical, Inc. NUEDEXTA (Drug) Food and Beverage In-kind items and services $12.87 General
Category: NEUROLOGY
10/04/2023 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $20.52 General
Category: Neuropsychiatry
08/22/2023 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $15.98 General
Category: PSYCHIATRY
08/10/2023 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug), REXULTI Food and Beverage In-kind items and services $21.13 General
Category: PSYCHIATRY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 217 296 $55,412 $27,715
2022 4 262 376 $78,323 $36,772
2021 9 356 473 $87,368 $49,320
2020 8 390 511 $97,582 $53,699
Total Patients
1,225
Total Services
1,656
Medicare Billing
$167,506
Procedure Codes
28

All Medicare Procedures & Services

28 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
90792 Psychiatric diagnostic evaluation with medical services Facility 2023 114 117 $30,991 $14,832 47.9%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 52 92 $9,571 $5,569 58.2%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 33 56 $8,969 $5,133 57.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 18 31 $5,881 $2,181 37.1%
90792 Psychiatric diagnostic evaluation with medical services Facility 2022 147 150 $41,995 $19,779 47.1%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 52 129 $18,189 $10,018 55.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 23 43 $8,041 $3,280 40.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 19 26 $4,862 $2,153 44.3%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2022 21 28 $5,236 $1,543 29.5%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 98 103 $28,092 $16,312 58.1%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 79 136 $19,074 $11,030 57.8%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 53 55 $10,230 $5,866 57.3%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2021 34 71 $9,946 $5,465 55.0%
99205 New patient outpatient visit, total time 60-74 minutes Facility 2021 21 21 $5,859 $2,981 50.9%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 18 25 $3,650 $1,986 54.4%
90791 Psychiatric diagnostic evaluation Facility 2021 14 14 $3,710 $1,758 47.4%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 11 16 $2,336 $1,532 65.6%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 11 11 $2,431 $1,196 49.2%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 17 21 $2,040 $1,194 58.5%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 156 163 $44,518 $26,146 58.7%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 88 145 $20,384 $11,902 58.4%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2020 33 61 $8,766 $5,051 57.6%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 37 62 $9,052 $3,422 37.8%
99205 New patient office or other outpatient visit, typically 60 minutes Facility 2020 19 19 $5,307 $2,228 42.0%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 20 20 $3,699 $2,108 57.0%

About Dr. John Baker, MD

Dr. John Baker, MD is a Psychiatry healthcare provider based in Lansing, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548225519.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Baker, MD has received a total of $21,224 in payments from pharmaceutical and medical device companies, with $332.58 received in 2024. These payments were reported across 340 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($14,900).

As a Medicare-enrolled provider, Baker has provided services to 1,225 Medicare beneficiaries, totaling 1,656 services with total Medicare billing of $167,506. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Location Lansing, MI
  • Active Since 04/20/2006
  • Last Updated 06/09/2017
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1548225519

Products in Payments

  • PERSERIS (Drug) $15,794
  • LATUDA (Drug) $990.99
  • REXULTI (Drug) $896.31
  • ABILIFY MAINTENA (Drug) $567.27
  • INVEGA SUSTENNA (Drug) $473.94
  • VRAYLAR (Drug) $467.89
  • Fanapt (Drug) $315.46
  • INGREZZA (Drug) $291.85
  • CAPLYTA (Drug) $205.56
  • ARISTADA (Drug) $187.61
  • AUSTEDO (Drug) $158.63
  • Aristada 441 mg (Drug) $154.37
  • NUEDEXTA (Drug) $146.04
  • BELSOMRA (Drug) $138.70
  • NUPLAZID (Drug) $67.90
  • Auvelity (Drug) $66.15
  • ABILIFY ASIMTUFII (Drug) $61.48
  • Trintellix (Drug) $51.51
  • TRINTELLIX (Drug) $29.83
  • VYVANSE (Drug) $28.60

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Lansing